LDL cholesterol is what most doctors order. Research increasingly shows ApoB is the superior cardiovascular risk marker. Here is what the data says.
Quick Summary ApoB (Apolipoprotein B) is the protein that carries LDL, VLDL, and IDL particles in the blood. Each atherogenic particle carries exactly one ApoB molecule -- making ApoB a direct count of the particles that cause plaque buildup. Research increasingly shows ApoB is a superior predictor of cardiovascular events compared to LDL-C. This article explains the science. Educational purposes only -- not medical advice.
LDL-C is a calculated estimate of the cholesterol carried inside LDL particles. This calculation becomes increasingly inaccurate when triglycerides are low -- a common finding in people on low-carbohydrate diets, GLP-1 therapy, or peptide protocols.
More importantly, LDL-C measures the cargo. ApoB counts the ships.
Track your ApoB alongside your full lipid panel at [myprotocolstack.com/labs](https://myprotocolstack.com/labs).
Every atherogenic lipoprotein particle -- LDL, VLDL, IDL, Lp(a) -- carries exactly one ApoB molecule. Research published in JAMA Cardiology, the European Heart Journal, and multiple meta-analyses consistently shows ApoB is a stronger predictor of cardiovascular events than LDL-C.
Research reference ranges:
GLP-1 Agonists -- Published SURMOUNT and STEP trials documented improvements in atherogenic particle counts alongside weight loss.
GH Peptides -- Tesamorelin trials documented changes in triglycerides and LDL. ApoB provides additional context.
Enclomiphene and TRT -- Some research shows favorable effects on lipid profiles; others show increases in LDL-C. ApoB provides a more accurate read of particle burden.
Lipoprotein(a) is highly atherogenic and not reflected in standard LDL-C measurements. Research shows Lp(a) above 50 mg/dL is associated with significantly elevated cardiovascular risk. Roughly 20% of the population carries elevated Lp(a) without knowing it.
|--------|----------------|
Enter all of these into [myprotocolstack.com/labs](https://myprotocolstack.com/labs) and [StackAI](https://myprotocolstack.com/stackai) will analyze the pattern across your full panel.
Should I ask my doctor for ApoB instead of LDL?
Many researchers and cardiologists now recommend ApoB as part of a comprehensive lipid panel. This is a conversation to have with your healthcare provider.
Can diet change my ApoB?
Published research shows dietary interventions can meaningfully reduce ApoB. The magnitude of response varies significantly between individuals.
Does GLP-1 therapy improve ApoB?
Published trials show ApoB reduction with both semaglutide and tirzepatide.
What is a dangerous ApoB level?
Research identifies ApoB above 100 mg/dL as elevated risk. Cardiovascular risk assessment requires integration of multiple factors.
Is ApoB covered by insurance?
Coverage varies. Function Health, Cleveland HeartLab, and Boston Heart Diagnostics routinely include it.
*This article is for educational purposes only. It does not constitute medical advice.*
*Written by the MyProtocolStack team. Last updated: January 2026.*
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.
Start Free →